Skip to content

Cipla gets 8% revenue from Indore plant. Can FDA warning lead to import hurdles?

Prolonged remedial work on the warnings issued may put Cipla#39;s FY26E earnings per share at risk, Jefferies has warned

Read More

​ Prolonged remedial work on the warnings issued may put Cipla#39;s FY26E earnings per share at risk, Jefferies has warned Prolonged remedial work on the warnings issued may put Cipla#39;s FY26E earnings per share at risk, Jefferies has warned  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish